EUVIMEDPoznaj EUVIMED
Crossref

Paeoniflorin Ameliorates Liver Fibrosis by Inhibiting HIF ‐1α‐Mediated Mitophagy in Hepatic Stellate Cells

Chunyu He, Yang Liu, Mengchen Qin, Wenyan Jia, Weicong Chen, Weiguang Chen, Binglian Zhong, Xuemei Yang, Huishan Lin, Yuyang Zhou, Bin Wen, Haitao Sun and 1 more

Phytotherapy Research · 2026-07 · 40 (7) · 3990-4004

DOI: 10.1002/ptr.70226 ↗

At a glance

Journal article in Phytotherapy Research, published online on 2026-04-22. Written by Chunyu He and 12 co-authors. Institution: Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China. Major MEDLINE topics: Hepatic Stellate Cells, Hypoxia-Inducible Factor 1, alpha Subunit, Glucosides, Mitophagy. Cited 1 times so far (Crossref); 32 references. Funded by: Natural Science Foundation of Guangdong Province, National Natural Science Foundation of China, Science and Technology Projects in Guangzhou.

AbstraktSubjectsDane bibliograficzneCiteRelated studies

Abstract (original language)

Paeoniflorin (PF) has exhibited significant anti‐hepatic fibrosis potential, yet its precise pharmacological mechanisms and molecular targets remain to be fully elucidated. This study aims to investigate the role of PF in modulating HIF‐1α‐mediated mitophagy both in vivo and in vitro, thereby elucidating its impact on liver fibrosis. The rat model of hepatic toxicity and chronic inflammation was established via CCl 4 injection, followed by preventive administration of PF in three dosage tiers (100, 150, 200 mg/kg/d). Additionally, HSC‐T6 cells were subjected to exposure to cobalt chloride (CoCl 2 , 200 μM) to mimic hypoxic conditions. Lentiviral transfection was employed to establish stable cell lines with either overexpression or knockdown of HIF‐1α, aiming to delineate the functional significance of HIF‐1α in hepatic stellate cells (HSCs) activation. The severity of liver inflammatory response and fibrotic progression was evaluated with several pathological stainings. Levels of mRNA were detected by qPCR. Expression levels of protein were assayed with Western blot. The protein content and distribution were also visually detected through IHC and IF staining. ROS was detected by DCFH‐DA, and mitochondrial membrane potential was quantitatively assessed using JC‐1 staining. Our results demonstrated that PF treatment significantly reversed CCl 4 ‐induced liver fibrosis, effectively reducing hepatic inflammation and oxidative damage. PF also inhibited mitophagy by suppressing the HIF‐1α pathway, thereby attenuating HSCs' activation. This study uncovers a novel mechanism involving HIF‐1α‐mediated mitophagy in HSCs and provides evidence that PF alleviates hepatic fibrosis by inhibiting this process, leading to reduced inflammation and oxidative damage. These findings suggest that PF could be a natural and vital medicine to treat liver fibrosis.

Subjects

MeSH terms (MEDLINE)

Hepatic Stellate CellsHypoxia-Inducible Factor 1, alpha SubunitGlucosidesMitophagyMonoterpenesLiver CirrhosisAnimalsRatsGlycosidesMaleRats, Sprague-DawleyCell LineReactive Oxygen SpeciesCarbon TetrachlorideMembrane Potential, Mitochondrial

Author keywords

HIF‐1αliver fibrosismitophagyoxidative stress damagepaeoniflorin

Substances

Hypoxia-Inducible Factor 1, alpha SubunitGlucosidesMonoterpenespeoniflorinGlycosidesHif1a protein, ratReactive Oxygen SpeciesCarbon Tetrachloride

Authors and institutions

  • Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
  • School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, People's Republic of China.
  • Affiliated Zhuhai Hospital, Southern Medical University (Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine), Zhuhai, China.
  • Department of Traditional Chinese Medicine, The Air Force Hospital of Southern Theatre Command of People's Liberation Army, Guangzhou, People's Republic of China.

ORCID profiles: Songqi He

Funding

  • Natural Science Foundation of Guangdong Province
  • National Natural Science Foundation of China
  • Science and Technology Projects in Guangzhou

Cite

APA

He, C., Liu, Y., Qin, M., Jia, W., Chen, W., Chen, W., Zhong, B., Yang, X., Lin, H., Zhou, Y., Wen, B., Sun, H., & He, S. (2026). Paeoniflorin Ameliorates Liver Fibrosis by Inhibiting HIF ‐1α‐Mediated Mitophagy in Hepatic Stellate Cells. Phytotherapy Research, 40(7), 3990-4004. https://doi.org/10.1002/ptr.70226

Vancouver

He C, Liu Y, Qin M, Jia W, Chen W, Chen W, et al. Paeoniflorin Ameliorates Liver Fibrosis by Inhibiting HIF ‐1α‐Mediated Mitophagy in Hepatic Stellate Cells. Phytotherapy Research. 2026;40(7):3990-4004. doi:10.1002/ptr.70226

BibTeX
@article{He2026,
  author = {He, Chunyu and Liu, Yang and Qin, Mengchen and Jia, Wenyan and Chen, Weicong and Chen, Weiguang and Zhong, Binglian and Yang, Xuemei and Lin, Huishan and Zhou, Yuyang and Wen, Bin and Sun, Haitao and He, Songqi},
  title = {Paeoniflorin Ameliorates Liver Fibrosis by Inhibiting HIF ‐1α‐Mediated Mitophagy in Hepatic Stellate Cells},
  journal = {Phytotherapy Research},
  year = {2026},
  volume = {40},
  number = {7},
  pages = {3990--4004},
  doi = {10.1002/ptr.70226}
}
Start for free →